TACE for HCC by TANDEM and Idarubicin

NCT03349957 · clinicaltrials.gov ↗

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

DRUG: Transarterial chemoembolization using TANDEM and idarubicin

Sponsor

University Hospital, Montpellier